inserted, in frame with YFP (or without YFP), into vector pBA002; therefore, plasmids pWYX-35S:GDI1(3A), pWYX-35S:GDI1(3D), pWYX-35S:YFP-GDI1(3A) and pWYX-35S:YFP-GDI1(3D) were constructed.
For expressing recombinant proteins in E. coli, CDS fragments of GDI1, GDI1(3A) , and GDI1(3A) were cloned into pGEX-6P1 vector (GE Healthcare, USA); CDS of ROP2, ROP6 and CPK3 were cloned into pET28a vector (Novagen, USA). Details on plasmids information can be found in Table S1 and Table S2 .
Generating transgenic plants and hybrid lines
Agrobacterium tumefaciens (strain GV3101) carrying corresponding plasmids were introduced into WT (Col-0) or gdi1-1 plants through the floral dip-mediated infiltration (Clough and Bent, 1998) . Transgenic lines overexpressing GDI1 gene were all generated in WT (Col-0) background. The transgenic lines carrying plasmids pWYX-CFP-ROP2, pWYX-CFP-ROP6, pWYX-CFP-CA-rop6(G15V) and pWYX-CFP-DN-rop6(T20N) were also generated in WT (Col-0) background. For each complementation lines, plasmids pWYX-35S:GDI1, pWYX-35S:GDI1(3A) and pWYX-35S:GDI1(3D)
were respectively transformed into gdi1-1 mutant plants; and then, transgenic lines with recovered expression level of GDI1 which was similar to that in WT were selected and named GDI1 (Com), 3A (Com) and 3D (Com). Homozygous plants were selected and further characterised in this study. At least twenty independent transgenic lines were produced in each transformation.
Transgenic plants carrying pWYX-CFP-ROP2 or pWYX-CFP-ROP6 were crossed with plants harboring pWYX-GDI1-YFP vector for in vivo FRET analysis. The hybrid lines GDI1 ROP6-WT, GDI1 CA-rop6 and GDI1 were generated by crossing GDI1-YFP into CFP-tagging ROP6 lines. The information about plasmids which were used for generating transgenic lines can be found in the Table S1 and Table S2 .
Transient expression assays
For BiFC transient expression assays, plasmids p35S:GDI1-YN and p35S:ROPs-YC or p35S:CPK3-YC were respectively transformed into Col-0 mesophyll protoplasts following the method described previously (Yoo et al., 2007; Wang et al., 2011 Table S1 and Table S2 .
2D gel electrophoresis and immunoblotting of total proteins
Total proteins were extracted from leaves tissues of 3-week-old GFP-GDI1-14 transgenic plants, which were harvested with liquid nitrogen. The homogenization buffer for extracting total protein contains 25 mM Tris-HCl (pH 7.5), 150 mM NaCl, 2 mM DTT, 1 mM NaF, 0.5 mM Na 3 VO 4 , 15 mM β-glycerophosphate, 0.5 mM PMSF and protease inhibitor cocktails (Roche Applied Science). After 40 minutes centrifugation (15,000 g) at 4 o C, the supernatant was desalted using the phenol-methanol method (Chen et al., 2011) . Total protein (100 µg) was separated by 2D gel electrophoresis using a 13 cm pH 4-7 IPG stripe (GE Healthcare, USA) and 10% SDS-PAGE gel as described previously (Yu and Guo, 2011) . The protein was then transferred to a PVDF membrane (GE Healthcare, USA) and GFP-GDI1 protein was detected with anti-GFP antibody (Proteintech Group, USA).
Identification of phosphorylation sites
Total protein was extracted in the way similar to that used for the 2D gel electrophoresis experiment. The homogenate was suspended in chilled homogenization buffer containing 25 mM Tris-HCl (pH 7.5), 150 mM NaCl, 2 mM DTT, 1 mM NaF, 0.5 mM Na 3 VO 4 , 15 mM β-glycerophosphate, 0.5 mM PMSF, phosphatase inhibitor cocktail (Roche Applied Science) and protease inhibitor cocktails (Roche Applied Science). Following centrifugation (15,000 g)
for 40 minutes at 4 o C, the supernatant was precipitated with 3 volumes of 50% acetone/50% ethanol/ 0.1% acetic acid; and then, the protein precipitation was dissolved in 8 M urea (Sigma, USA), reduced in 10 mM DTT (Sigma, USA) and alkylated with 40 mM iodoacetamide (Sigma, USA). Next, collected proteins were digested with trypsin for overnight and desalted afterwards (Chen et al., 2011) . Through enrichment with IMAC column (Chen et al., 2011) , the phosphopeptides were separated by high performance liquid chromatography (HPLC) and used for RPLC-ESI-MS/MS (Applied Biosystems, USA) analysis as described previously (Chen et al., 2011) .
Pharmacologic treatments
For the 2-APB (2-aminoethyl diphenylborinate, Sigma) treatment, seedlings 
